Literature DB >> 9374737

Rat alveolar macrophages express preprotachykinin gene-I mRNA-encoding tachykinins.

C R Killingsworth1, S A Shore, F Alessandrini, R D Dey, J D Paulauskis.   

Abstract

Although the tachykinins substance P (SP) and neurokinin A have been largely localized to neurons, eosinophils have also been shown to express these peptides. Our aim was to determine whether rat alveolar macrophages (AM) express preprotachykinin gene-I (PPT-I) mRNA that encodes these tachykinins and to examine expression during inflammation. PPT-I mRNA was detected by reverse transcription (RT)-polymerase chain reaction (PCR) in AM and brain (control) but not in peritoneal macrophages. Northern analysis showed that PPT-I mRNA was induced two- to fourfold by in vivo treatment of rats with intratracheal lipopolysaccharide (LPS) and in vitro after 4 h of exposure to LPS. This increase was inhibited by dexamethasone. In situ RT-PCR and immunocytochemistry further confirmed that AM express PPT-I mRNA and SP-like immunoreactivity, respectively, which was enhanced by LPS treatment. A 1.3-kb transcript consistent with PPT-I mRNA was detected by Northern analysis of bronchoalveolar lavage neutrophils. Therefore, rat AM express PPT-I mRNA that is upregulated in AM by LPS and is attenuated by dexamethasone. PPT-I mRNA was also detected in lung neutrophils.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374737     DOI: 10.1152/ajplung.1997.273.5.L1073

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Translocation of Bax and Bid to mitochondria, endoplasmic reticulum and nuclear envelope: possible control points in apoptosis.

Authors:  Barbara Gajkowska; Urszula Wojewódzka; Joanna Gajda
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

2.  Knockout of the Tachykinin Receptor 1 in the Mdr2-/- (Abcb4-/-) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis.

Authors:  Ludovica Ceci; Heather Francis; Tianhao Zhou; Thao Giang; Zhihong Yang; Fanyin Meng; Nan Wu; Lindsey Kennedy; Konstantina Kyritsi; Vik Meadows; Chaodong Wu; Suthat Liangpunsakul; Antonio Franchitto; Amelia Sybenga; Burcin Ekser; Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2020-07-23       Impact factor: 4.307

3.  Substance P receptor blockade decreases stretch-induced lung cytokines and lung injury in rats.

Authors:  Fabienne Brégeon; Jean Guillaume Steinberg; Nicolas Andreotti; Jean-Marc Sabatier; Stéphane Delpierre; Sylvie Ravailhe; Yves Jammes
Journal:  J Physiol       Date:  2010-02-22       Impact factor: 5.182

4.  Role of neurokinin-1 receptor in the initiation and maintenance of skin chronic inflammatory diseases.

Authors:  Sherrie J Divito; Adrian E Morelli; Adriana T Larregina
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

5.  Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.

Authors:  R A Tripp; D Moore; J Winter; L J Anderson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Bone marrow transplantation reveals an essential synergy between neuronal and hemopoietic cell neurokinin production in pulmonary inflammation.

Authors:  Mara Chavolla-Calderón; Meggan K Bayer; J Julio Pérez Fontán
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 7.  Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Authors:  Susmit Suvas
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

8.  Colocalization of substance P with tumor necrosis factor-α in the lymphocytes and mast cells in gastritis in experimental rats.

Authors:  Éva Pongor; Károly Altdorfer; Erzsébet Fehér
Journal:  Inflamm Res       Date:  2010-09-24       Impact factor: 4.575

9.  Effects of endogenous substance P expression on degranulation in RBL-2H3 cells.

Authors:  Hua Hu; Ruxin Zhang; Xiaoyun Fang; Min Yu; Shaoqing Yu; Jie Zhang; Hong Wang
Journal:  Inflamm Res       Date:  2010-12-29       Impact factor: 4.575

10.  Evaluating the suitability of using rat models for preclinical efficacy and side effects with inhaled corticosteroids nanosuspension formulations.

Authors:  Po-Chang Chiang; Yiding Hu; Jason D Blom; David C Thompson
Journal:  Nanoscale Res Lett       Date:  2010-04-10       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.